CCR6 and Miyoshi myopathy: Chemokine (C-C motif) ligand 20 (CCL-20), also known as macrophage inflammatory protein-3α (MIP-3α), and its receptor CCR6 are upregulated in the bone microenvironment by MM cells and contribute to osteoclast formation and osteolytic bone lesions in MM patients [34].